313 PHARMA LTD
Company number 13449231 · Active · Birmingham B12 9DR
313 PHARMA LTD is an active private limited company (company number 13449231) incorporated on 10 June 2021, registered in Birmingham. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 30 June 2025, showing net assets of £401 and cash of £1,773, with 10 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 104% on the prior period (−£9,891).
By net assets it sits in the upper half of 88 comparable companies in Birmingham (median £100, upper quartile £25k).
Key dates
- Incorporated
- 10 June 2021
- Next accounts due
- 30 March 2027 — in 159 days
- Confirmation statement due
- 24 June 2027 — in 245 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Unaudited Abridged
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 June 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £401 | £1,773 | £281k | £789k | — | — | 10 |
| 30 June 2024 | −£9,891 | £3,511 | £282k | £725k | — | — | 10 |
- Current ratio
- 1.11
- Cash per employee
- £177
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 76/100 (grade B)
- +10 Positive net assets — Net assets £401 at 2025-06-30
- +8 Net assets growing — +104.1% vs prior period
- +8 Established — Incorporated 2021-06-10 (5 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Shaneabbas Remtulla — owns 75–100% of shares; holds 75–100% of voting rights · since 20 June 2022
- Mr Shaneabbas Remtulla — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 10 June 2021 · ceased 20 June 2022
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Birmingham
Same activity (wholesale of pharmaceutical goods), closest in incorporation date.
- MASH PHARMACEUTICALS LTD — Birmingham, inc. Jul 2021
- HEALTH CARE SUPPLY SOLUTIONS LTD — Birmingham, inc. Apr 2021
- ZANEX PHARMACEUTICALS LTD — Birmingham, inc. Apr 2021
- SHARMA CAPITAL LTD — Wolverhampton, inc. Aug 2021
- ASCOT PHARMACEUTICALS LTD — Dudley, inc. Mar 2021
- OMNIONE TECHNOLOGIES LIMITED — Birmingham, inc. Feb 2021
All companies incorporated on 10 June 2021 · in Jun 2021.
Reminders for 313 PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.